Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:727-732
Published online before print February 5, 2004, doi: 10.1161/01.ATV.0000120373.95552.aa
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
24/4/727    most recent
01.ATV.0000120373.95552.aav1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zettler, M. E.
Right arrow Articles by Pierce, G. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zettler, M. E.
Right arrow Articles by Pierce, G. N.
Related Collections
Right arrow Risk Factors
Right arrow Cell signalling/signal transduction
Right arrow Gene regulation
Right arrow Physiological and pathological control of gene expression
Right arrow Mechanism of atherosclerosis/growth factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:727.)
© 2004 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Oxidized Low-Density Lipoprotein Retards the Growth of Proliferating Cells by Inhibiting Nuclear Translocation of Cell Cycle Proteins

Marjorie E. Zettler; Michele A. Prociuk; J. Alejandro Austria; Guangming Zhong; Grant N. Pierce

From the Cell Biology Laboratory, Division of Stroke and Vascular Disease, St Boniface General Hospital Research Centre, Winnipeg, Manitoba, Canada; the Department of Physiology, University of Manitoba, Winnipeg, Manitoba, Canada; and the Department of Microbiology (G.Z.), University of Texas Health Science Center at San Antonio, TX.

Correspondence to Dr Grant N. Pierce, Division of Stroke and Vascular Disease, Saint Boniface General Hospital Research Centre, 351 Tache Ave, Winnipeg, Manitoba, Canada R2H 2A6. E-mail gpierce{at}sbrc.ca

Objective— Our study tested the hypothesis that the mitogenic effect of oxidized low-density lipoprotein (oxLDL) on vascular cells may be further enhanced by the presence of cytokines and growth factors known to be present in the atherosclerotic environment.

Methods and Results— Quiescent fibroblasts and vascular smooth muscle cells were treated with 10 or 50 µg/mL minimally-oxidized LDL in combination with serum for 24 or 48 hours. Surprisingly, these cells showed inhibited release from growth arrest and a significant reduction in the number of cells completing the cell cycle when compared with cells treated with serum alone. This was not due to an induction of apoptosis. The antiproliferative effects were not closely associated with changes in the expression of cell cycle proteins. Instead, oxLDL inhibited the translocation of cell cycle proteins cell division cycle (Cdc) 2, cyclin-dependent kinase (Cdk) 2, Cdk 4, Cyclin A, Cyclin B1, Cyclin D1, and proliferative cell nuclear antigen (PCNA) into the nucleus, as compared with separate treatments with serum alone. Kinase activation associated with specific cell cycle proteins was also inhibited by oxLDL.

Conclusions— oxLDL, in the presence of serum, has a surprising inhibitory effect on cell proliferation that occurs through an inhibition of import of cell cycle proteins into the cell nucleus.


Key Words: atherosclerosis • cyclin • kinase, cyclin-dependent • cell proliferation




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
M. N. Chahine and G. N. Pierce
Therapeutic Targeting of Nuclear Protein Import in Pathological Cell Conditions
Pharmacol. Rev., September 1, 2009; 61(3): 358 - 372.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. S. Faustino, P. Cheung, M. N. Richard, E. Dibrov, A. L. Kneesch, J. F. Deniset, M. N. Chahine, K. Lee, D. Blackwood, and G. N. Pierce
Ceramide regulation of nuclear protein import
J. Lipid Res., March 1, 2008; 49(3): 654 - 662.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. O. Apostolov, A. G. Basnakian, X. Yin, E. Ok, and S. V. Shah
Modified LDLs induce proliferation-mediated death of human vascular endothelial cells through MAPK pathway
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1836 - H1846.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. X.-F. Deng, J. M. Spin, A. Tsalenko, A. Vailaya, A. Ben-Dor, Z. Yakhini, P. Tsao, L. Bruhn, and T. Quertermous
Molecular Signatures Determining Coronary Artery and Saphenous Vein Smooth Muscle Cell Phenotypes: Distinct Responses to Stimuli
Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 1058 - 1065.
[Abstract] [Full Text] [PDF]